LeMaitre Vascular - Stock Price History | LMAT

Historical daily share price chart and data for LeMaitre Vascular since 2019 adjusted for splits. The latest closing stock price for LeMaitre Vascular as of October 15, 2019 is 33.76.
  • The all-time high LeMaitre Vascular stock closing price was 41.02 on April 19, 2018.
  • The LeMaitre Vascular 52-week high stock price is 36.06, which is 6.8% above the current share price.
  • The LeMaitre Vascular 52-week low stock price is 21.79, which is 35.5% below the current share price.
  • The average LeMaitre Vascular stock price for the last 52 weeks is 28.50.
LeMaitre Vascular Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 33.3878 31.1200 41.0200 22.0100 23.6400 -25.75%
2017 30.1878 25.2300 39.1300 21.9000 31.8400 25.65%
2016 17.3402 15.8200 25.4600 12.5000 25.3400 46.90%
2015 11.2922 7.8200 17.7700 7.2900 17.2500 125.49%
2014 7.6054 8.0000 8.3900 6.6000 7.6500 -4.49%
2013 6.7398 5.7600 8.6500 5.7600 8.0100 39.55%
2012 5.8998 5.7400 6.5000 5.0000 5.7400 -3.04%
2011 6.6180 6.9400 7.5000 5.2800 5.9200 -12.56%
2010 5.7450 4.9800 7.2800 4.4200 6.7700 35.40%
2009 3.2835 2.1400 5.0000 1.9100 5.0000 116.64%
2008 3.5810 6.0000 6.7100 1.8600 2.3080 -62.77%
2007 6.4814 6.0500 7.6500 5.5600 6.2000 3.33%
2006 5.9806 6.2000 6.4500 5.5000 6.0000 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.622B $0.106B
LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $144.337B 20.26
Abbott Laboratories (ABT) United States $140.738B 26.45
Stryker (SYK) United States $79.987B 27.66
Boston Scientific (BSX) United States $53.253B 25.83
Baxter (BAX) United States $44.944B 27.25
EssilorLuxottica Societe Anonyme (ESLOY) France $32.375B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.013B 17.93
Coloplast (CLPBY) Denmark $24.818B 39.62
Lonza Group Ag (LZAGY) Switzerland $24.634B 0.00
Terumo (TRUMY) Japan $23.332B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $20.543B 0.00
ResMed (RMD) United States $18.641B 35.52
Sunny Optical Technology (SNPTF) China $16.343B 0.00
Bio-Rad Laboratories (BIO) United States $9.871B 52.91
Insulet (PODD) United States $9.245B 547.82
Perrigo (PRGO) Ireland $7.271B 13.39
Canopy Growth (CGC) Canada $6.759B 0.00
Hill-Rom Holdings (HRC) United States $6.636B 19.78
Haemonetics (HAE) United States $6.525B 49.24
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.322B 27.49
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $3.786B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.537B 0.00
Neogen (NEOG) United States $3.350B 56.05
NuVasive (NUVA) United States $3.316B 26.44
ICU Medical (ICUI) United States $3.170B 20.56
Quidel (QDEL) United States $2.389B 23.72
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.290B 0.00
Agios Pharmaceuticals (AGIO) United States $1.917B 0.00
National Vision Holdings (EYE) United States $1.879B 40.56
Cardiovascular Systems (CSII) United States $1.641B 0.00
Aphria (APHA) $1.187B 0.00
VAREX IMAGING (VREX) United States $1.080B 24.88
AtriCure (ATRC) United States $1.009B 0.00
Phibro Animal Health (PAHC) United States $0.855B 13.90
Eagle Pharmaceuticals (EGRX) United States $0.821B 20.92
Omeros (OMER) United States $0.756B 0.00
NanoString Technologies (NSTG) United States $0.753B 0.00
Lantheus Holdings (LNTH) United States $0.737B 19.38
PetIQ (PETQ) United States $0.712B 16.81
Cerus (CERS) United States $0.630B 0.00
Surmodics (SRDX) United States $0.573B 109.00
MacroGenics (MGNX) United States $0.556B 0.00
Quanterix (QTRX) United States $0.547B 0.00
TG Therapeutics (TGTX) United States $0.493B 0.00
OraSure Technologies (OSUR) United States $0.475B 22.00
Owens & Minor (OMI) United States $0.399B 11.94
Meridian Bioscience (VIVO) United States $0.382B 11.93
Zynex (ZYXI) United States $0.379B 40.31
Utah Medical Products (UTMD) United States $0.347B 25.45
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.311B 0.00
BioLife Solutions (BLFS) United States $0.309B 95.06
United Health Products (UEEC) United States $0.245B 0.00
Bovie Medical (APYX) United States $0.235B 0.00
Vapotherm (VAPO) United States $0.175B 0.00
Rockwell Medical (RMTI) United States $0.160B 0.00
Cytosorbents (CTSO) United States $0.151B 0.00
Female Health (VERU) United States $0.135B 0.00
Fonar (FONR) United States $0.128B 9.00
InfuSystems Holdings (INFU) United States $0.128B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
Chimerix (CMRX) United States $0.095B 0.00
United-Guardian (UG) United States $0.085B 20.14
Nephros (NEPH) United States $0.071B 0.00
MTech Acquisition (KERN) United States $0.063B 0.00
MRI Interventions (MRIC) United States $0.056B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Surface Oncology (SURF) United States $0.034B 0.00
Senestech (SNES) United States $0.024B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
GUARDION HEALTH (GHSI) United States $0.021B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Myomo (MYO) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.009B 0.00
Valeritas Holdings (VLRX) United States $0.006B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00